BAPS - Pramukh Swami Hospital
Surat, Gujarat, India
Hospital in Surat, Gujarat
5QQX+R72, Shri Pramukh Swami Maharaj Marg,, Adajan Char Rasta, Adajan, Surat, Gujarat 395009
About BAPS - Pramukh Swami Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Galapagos NV
2
Pfizer
2
Janssen Vaccines & Prevention B.V.
1
Kowa Research Institute, Inc.
1
Novartis Pharmaceuticals
1
Torrent Pharmaceuticals Limited
1
Zydus Lifesciences Limited
1
Clinical Trials at BAPS - Pramukh Swami Hospital
During the past decade, BAPS - Pramukh Swami Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
2017-07-11
2024-08-01
Active, not recruiting
139
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
2018-03-12
2022-08-01
Unknown status
1,250
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
2018-01-03
2020-04-30
Terminated
334
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "BAPS - Pramukh Swami Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Galapagos NV" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Kowa Research Institute, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "BAPS - Pramukh Swami Hospital"
#1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Molecular Partners AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at BAPS - Pramukh Swami Hospital
According to Clinical.Site data, the most researched conditions in "BAPS - Pramukh Swami Hospital" are
"Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Influenza A" (2 trials), "Anemia" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "BAPS - Pramukh Swami Hospital" in a lesser frequency.
Clinical Trials Intervention Types at BAPS - Pramukh Swami Hospital
Most popular intervention types in "BAPS - Pramukh Swami Hospital" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (2 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at BAPS - Pramukh Swami Hospital
The vast majority of trials in "BAPS - Pramukh Swami Hospital" are
11 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at BAPS - Pramukh Swami Hospital
Currently, there are NaN active trials in "BAPS - Pramukh Swami Hospital".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in BAPS - Pramukh Swami Hospital,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in BAPS - Pramukh Swami Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".